Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Krystle Karoscik
INNOVOTEX Secures Strategic Financing to Advance NOVO-111 Toward IND
AUSTIN, TX, UNITED STATES, August 11, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a pharmaceutical company developing Macrocycle Drug Conjugates (MDCs) designed to improve the therapeutic index of established cancer therapies, today announced the close of a strategic financing that will fund IND-enabling development of its lead oncology candidate, NOVO-111.
INNOVOTEX Announces Company Overview to Highlight Advancement of NOVO-111 and Macrocycle Drug Conjugate Platform
AUSTIN, TX, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- INNOVOTEX today announced an upcoming company overview focused on the continued advancement of its proprietary Macrocycle Drug Conjugate (MDC) platform and lead therapeutic candidate, NOVO-111.
INNOVOTEX Appoints Dr. Krystle Karoscik as CEO to Advance Macrocycle Drug Conjugate Platform into the Clinic
AUSTIN, TX, UNITED STATES, May 14, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a pharmaceutical company advancing a new class of tumor-selective oncology therapeutics known as Macrocycle Drug Conjugates (MDCs), today announced the appointment of Dr. Krystle Karoscik to Chief Executive Officer and Board Director. Dr. Karoscik will lead the company’s translational and corporate strategy as INNOVOTEX advances its lead candidate, NOVO-111, through first-in-human clinical trials.
77 Countries Just Received 173 Million COVID-19 Doses
Until last week, roughly 62.8 million COVID inoculations had been distributed in the U.S., and 43.2 million doses had been administered in Canada, according to the Centers for Disease Control and Prevention (CDC). These totals do not include the vaccines distributed to the Bureau of Prisons, Department of Defense, Indian Health Service, or Veteran’s Health Administration.
How to Sell the COVID-19 Vaccine
One COVID-19 vaccine just received emergency use authorization and another is pending. the next important task will be getting the public vaccinated. To say its release will be fraught is an understatement.
COVID-19’s Long-Lasting Impact on Clinical Trials
With COVID-19 impacting the conduct of clinical trials, a lot of discussion has been around what changes have allowed trials to continue recruitment. Each clinical trial is different and many oncology trials deal with specific patient populations—and these patients have few options outside of participating in a trial as they are dealing with a critical, life-threatening disease.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Krystle
Contact Krystle, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack